Filing Flows › Pulse Biosciences (PLSE) › Q4 2025
Pulse Biosciences (PLSE) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 19, 2026
Pulse Biosciences (PLSE) reported revenue of $264K for the fourth quarter 2025 (Q4 2025) and +207% from the quarter before.
Pulse Biosciences, Q4 2025: revenue $264K, net loss $17.4M, operating cash flow −$14.8M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $264K | +207% | — |
| Operating profit | −$18.3M | — | — |
| Net earnings | −$17.4M | — | — |
| Operating cash flow | −$14.8M | — | — |
What changed
Revenue was $264K in Q4 2025, up 207% from the previous quarter.
Operating costs exceeded revenue by $18.3M, an operating margin of -6914.0%. The quarter ended with a net loss of $17.4M, narrower than the previous quarter's $19.4M loss.
Operating cash flow was −$14.8M. Non-cash charges added back $259K of depreciation and amortization and $5.0M of share-based compensation. Working capital and other items used $2.6M. Capital expenditures of $105K exceeded it, leaving free cash flow of −$14.9M.
Questions
What was Pulse Biosciences' revenue in the fourth quarter 2025?
Pulse Biosciences (PLSE) reported revenue of $264K for the fourth quarter 2025 (Q4 2025) and +207% from the quarter before.
Source: Pulse Biosciences 10-K on SEC EDGAR.